Effectiveness of MGSO4 Administration Against Prevention of Eclampsia in Severe Pre-Eclampsia in RSIA Resti Mulya in 2022
Keywords:
severe pre-eclampsia, Eclampsia Prevention, MgSo4Abstract
Aims: To determine the Effectiveness of Mgso4 Administration against Eclampsia Prevention in severe pre-eclampsia in RSIA Resti Mulya in 2022.
Methods: This study used the Quasy Experimental quantitative method, with a retrospective approach. The relationship between the two variables in this study was tested using the dependent paired t-test data analysis technique. The population of this study was all mothers who were severely eclampsia and received MgSo4 therapy as many as 43 respondents, using a total sampling of which all populations were made respondents.
Results: Frequency distribution of characteristics of respondents aged 30.8 years with a gestational age of 37.6 weeks with an obese Body Mass Index (30-39.5) of 39.5%, having a history of peer disease of 81.4%, and the number of multipara childbirth as much as 69.8%. Differences in the prevention of eclampsia (blood pressure and urine protein) in severe pre-eclampsia before and after administration of MgSo4, namely Sistol values of 163.8 vs 121.4. Diastole pressure value of 105.5 vs 80.4. urine protein 1.52. There is the effectiveness of mgso4 administration against the Prevention of eclampsia in severe pre-eclampsia at RSIA Resti Mulya in 2022 with a p-value value: 0.000.
Conclusion: The results of this study are that the administration of MgSo4 effectively prevents eclampsia in severe pre-eclampsia at RSIA Resti Mulya in 2022. Thus, it is expected to refer to the importance of giving MgSo4 to mothers with pre-eclampsia.
References
WHO. Maternal mortality. 2019.
WHO. WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia. Organization WH, editor. Geneva; 2011. 38 p.
Depkes RI. Reference Book: Basic Emergency Neonatal Obstetric Services. Indonesia DKR, editor. Jakarta: Departemen Kesehatan Republik Indonesia; 2007.
Than NG, Romero R, Tarca AL, Kekesi KA, Xu Y, Xu Z, et al. Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia. Front Immunol. 2018;9:1661.
Oliveira LG De, Diniz ALD, Prado CA de C, Cunha Filho EV Da, Souza FLP De, Korkes HA, et al. Pre-eclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings? Rev Bras Ginecol e Obs. 2021;43:61–5.
El-Sayed AAF. Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol. 2017;56(5):593–8.
Noroyono W, Irwinda R, Frisdiantiny E, Karkata MK, Mose JC, Chalid MT, et al. National Guidelines for Medical Services for Diagnosis and Management of Pre-Eclampsia. 2016;
Langston-Cox AG, Marshall SA, Palmer KR, Wallace EM. Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol. BMJ Open. 2019;9(10):e027493.
Saidah S, Yusup N. Relationship of administration of magnesium (MgSO4) in pre-eclampsia/eclampsia pregnancy to the incidence of asphyxia in BBL in Samarinda Islamic Hospital. J Kebidanan Mutiara Mahakam. 2016;4(2):11–20.
Haryanti D, Nurdiani L. RELATIONSHIP OF AGE AND PREECLAMATION WITH THE EVENT OF LOW BIRTH WEIGHT IN RADEN MATTAHER HOSPITAL JAMBI. MIDWIFERY Heal J. 2021;6(1):1–6.
Amalia FF. THE EFFECT OF USING MGSO4 AS SEQUEL PREVENTION THERAPY ON PREECLAMPSIA. J Ilmu Kedokt dan Kesehat. 2020;7(1).
Veftisia V, Afriyani LD. Levels of Anxiety, Stress, and Depression in Second and Third Trimester Pregnant Women at PMB Alam, Salatiga City. Indones J Midwifery. 2021;4(1):62–7.
Situmorang TH, Damantalm Y, Januarista A, Sukri S. Factors related to the incidence of preeclampsia in pregnant women at the MCH Polyclinic, Anutapura Hospital, Palu. Heal Tadulako J (Jurnal Kesehat Tadulako). 2016;2(1):34–44.
Novianti H. Effect of Age and Parity on the Incidence of Pre-Eclampsia in Sidoarjo Hospital. J Heal Sci. 2016;9(1).
Andriani R, Apriani S. Effect of Gentle Birth Method on Pain Level and Duration of First Stage of Labor in Primiparous Mothers. JOMIS (Journal Midwifery Sci. 2021;5(1):28–35.
Lisnawati Y, Sakti J, Irwinda R, Agustin K, Nurfauziah N. A Significant Increase in Maternal Blood Uric Acid Levels Accompanies the Severity of Hypertensive Disorders in Pregnancy. Indones J Obstet Gynecol. 2021;144–8.
Cipolla MJ, Kraig RP. Seizures in women with preeclampsia: mechanisms and management. Fetal Matern Med Rev. 2011;22(2):91–108.
Tanz LJ, Stuart JJ, Missmer SA, Rimm EB, Sumner JA, Vadnais MA, et al. Cardiovascular biomarkers in the years following pregnancies complicated by hypertensive disorders or delivered preterm. Pregnancy Hypertens. 2018;13:14–21.
